Cross Sectional CFAR HIV/COVID-19 Study

Completed

• Conditions: SARS-CoV Infection; Covid19

• Registration Number: NCT04514016
• Lead Sponsor: University of Miami

Brief Summary

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-08-12
• Study First Submitted: 2020-08-13
• Study First Submitted QC: 2020-08-13
• Study First Posted: 2020-08-14
• Status Verified: 2021-03
• Primary Completion: 2021-03-17
• Study Completion: 2021-03-17
• Last Update Submitted: 2021-03-22
• Last Update Posted: 2021-03-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• Being a patient to the Pediatric or Adolescent clinic located at Batchelor Children Research Institute (BCRI)
• Being diagnosed with HIV infection by the time of enrollment
• At enrollment, 3 to < 26 years

Exclusion Criteria

• Patient will be excluded from the study if any of the following are identified:
• Patients under legal age and in the State's custody
• Participant or legal guardian unable to sign Informed Consent forms
• Participant unable to complete study visits

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of participants who tested positive with SARS COV-2 Infection	month 3	SARS COV-2 Infection will be analyzed from nasopharyngeal swab samples via RT-PCR assay
Number of participants who tested positive with SARS COV-2 antibody	month 3	SARS COV-2 antibody will be analyzed from blood samples via serological assay

Trial Locations

Locations (1)

Batchelor's Children's Research Institute; 🇺🇸 Miami, Florida, United States